Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 4Lymphoma 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Nodule 1Sinusitis 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Mouth Neoplasms 1Melanoma 1Lymphatic Metastasis 1Hearing Loss 1Glioma 1Colonic Neoplasms 1Cholesteatoma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

Cyclophosphamide 8fludarabine 7pembrolizumab 6aldesleukin 4Interleukin-2 3spartalizumab 2fludarabine phosphate 2entinostat 2Vorinostat 2Trastuzumab 2Nivolumab 2Erlotinib Hydrochloride 2Biopsy 2Adoptive Transfer 2trastuzumab deruxtecan 1tislelizumab 1tipifarnib 1prexasertib 1oncogene protein E7, Human papillomavirus type 16 1nanocis 1enzalutamide 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1abiraterone 1Tomography, X-Ray Computed 1Thalidomide 1Technetium-99 1Taxes 1SRA737 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Magnetic Resonance Imaging × Head & Neck × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡